Sacroiliitis in Systemic Lupus Erythematosus Revisited

Neslihan YILMAZ, Ayten YAZICI, Banu ÖZULU TÜRKMEN, Işık KARALOK, Şule YAVUZ

DOI: 10.46497/ArchRheumatol.2020.7514

Issue: Volume 35 - Issue 2 - June 2020
9757 3213

Prevalence of Spondyloarthritis Among Patients Who Underwent Lumbar Disc Herniation Surgery

Özgül SOYSAL GÜNDÜZ, Servet AKAR, Dilek SOLMAZ, Gerçek CAN, Fatoş ÖNEN, Nurullah AKKOÇ

DOI: 10.46497/ArchRheumatol.2020.7323

Issue: Volume 35 - Issue 2 - June 2020
2893 2222

The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis

Serdar KOKAR, Önder KAYHAN, Savaş ŞENCAN, Osman Hakan GÜNDÜZ

DOI: 10.46497/ArchRheumatol.2021.8043

Issue: Volume 36 - Issue 1 - March 2021
2941 2298

Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs

Shiyi Deng, Yi He, Sisi Deng, Erwei Sun, Li Li

DOI: 10.46497/ArchRheumatol.2022.8485

Issue: Volume 37 - Issue 2 - June 2022
1714 1867

Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study

Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak

DOI: 10.46497/ArchRheumatol.2022.8645

Issue: Volume 37 - Issue 2 - June 2022
10909 2267

The comparison of effects of balneotherapy, water-based and land-based exercises on disease activity, symptoms, sleep quality, quality of life and serum sclerostin level in patients with ankylosing spondylitis: A prospective, randomized study

Ersin Bestaş, Ümit Dündar, Tülay Köken, Buğra Koca, Hilal Yeşil

DOI: 10.46497/ArchRheumatol.2022.9024

Issue: Volume 37 - Issue 2 - June 2022
2671 2956

Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar

H. Fatih Çay, Meltem Alkan Melikoğlu, Fatma Gül Yurdakul, Hatice Bodur, Şebnem Ataman, Erhan Çapkın, Gülcan Gürer, İlhan Sezer, M. Tuncay Duruöz, Aylin Rezvani, İlker Yağcı, Feride Göğüş, Ayhan Kamanli, Remzi Çevik, Özgür Akgül

DOI: 10.46497/ArchRheumatol.2023.9793

Issue: Volume 38 - Issue 3 - September 2023
1287 1031

Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

Emine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, Suade Özlem Badak, Emre Bilgin, Umut Kalyoncu, Burcu Yağız, Yavuz Pehlivan, Orhan Küçükşahin, Abdulsamet Erden, Dilek Solmaz, Pamir Atagündüz, Gezmiş Kimyon, Cemal Beş, Seda Çolak, Rıdvan Mercan, Timuçin Kaşifoğlu, Hakan Emmungil, Nilüfer Alpay Kanıtez, Aşkın Ateş, Süleyman Serdar Koca, Sedat Kiraz, İhsan Ertenli

DOI: 10.46497/ArchRheumatol.2023.9504

Issue: Volume 38 - Issue 3 - September 2023
1793 1270

Beyond the horizon: Innovations and future directions in axial-spondyloarthritis

Vincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, Fabian Proft

DOI: 10.46497/ArchRheumatol.2023.10580

Issue: Volume 38 - Issue 4 - December 2023
2228 2118

The relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis

Gunay Er, Deniz Palamar, Kenan Akgün, İbrahim Asoğlu, Hidayet Sarı

DOI: 10.46497/ArchRheumatol.2024.10224

Issue: Volume 39 - Issue 2 - June 2024
983 603

Alarming serum antiprotease levels in axial spondyloarthritis

Ayhan Kul, Zeynep Tüzün, Muhammet Çelik

DOI: 10.46497/ArchRheumatol.2024.10466

Issue: Volume 39 - Issue 2 - June 2024
785 474

Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in Türkiye

Erkan Kılıç, Gamze Kılıç, İbrahim Tekeoğlu, Betül Sargın, Sevtap Acer Kasman, Hakan Alkan, Nilay Şahin, Gizem Cengiz, Nihan Cüzdan, İlknur Albayrak Gezer, Dilek Keskin, Cevriye Mülkoğlu, Hatice Reşorlu, İsmihan Sunar, Ajda Bal, Mehmet Tuncay Duruöz, Okan Küçükakkaş, Ozan Volkan Yurdakul, Meltem Alkan Melikoğlu, Yıldıray Aydın, Fikriye Figen Ayhan, Hatice Bodur, Mustafa Çalış, Erhan Çapkın, Gül Devrimsel, Kevser Orhan, Sami Hizmetli, Ayhan Kamanlı, Yaşar Keskin, Hilal Ecesoy, Öznur Kutluk, Nesrin Şen, Ömer Faruk Şendur, Sena Tolu, Murat Toprak, Tiraje Tuncer, Kemal Nas

DOI: 10.46497/ArchRheumatol.2024.10591

Issue: Volume 39 - Issue 3 - September 2024
753 648

Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?

Rezan Koçak Ulucaköy, Ayza Kılıç, Sevilay Batıbay, İdil Melis Çobanoğlu, Elif Nur Yıldırım Öztürk, Zafer Günendi, Aylin Sepici Dinçel, Feride Nur Göğüş

DOI: 10.46497/ArchRheumatol.2024.10360

Issue: Volume 39 - Issue 3 - September 2024
491 450